MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Vitamin D to treat allergy in cystic fibrosis patients

Back to allergy news Blogs list Cancer blog  


Subscribe To Allergy News RSS Feed  RSS content feed What is RSS feed?

Vitamin D to treat allergy in cystic fibrosis patients




Aug. 25 Vitamin D appears to be an effective treatment to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma, as per scientists from Children's Hospital of Pittsburgh of UPMC, the University of Pittsburgh School of Medicine and Louisiana State University School of Medicine.

Results of the study, led by Jay Kolls, M.D., Ph.D., a lung disease researcher at Children's Hospital and professor of pediatrics at the University of Pittsburgh School of Medicine, are reported in the September 2010 issue of the Journal of Clinical Investigation



Vitamin D to treat allergy in cystic fibrosis patients

Aspergillus fumigatus, is one of the most common airborne molds and while it does not cause illness in the vast majority of those who inhale it, it can cause life threatening allergic symptoms in patients with cystic fibrosis. As a number of as 15 percent of patients with cystic fibrosis will develop a severe allergic response, known as Allergic Bronchopulmonary Aspergillosis (ABPA). Some patients with asthma also can develop ABPA.

The research team led by Dr. Kolls studied cystic fibrosis patients from the Antonio J. and Janet Palumbo Cystic Fibrosis Center at Children's Hospital who had A. fumigatus infections. One group had developed ABPA, while the other hadn't. The scientists observed that the ABPA patients had a heightened response by immune cells known as type 2 T helper (Th2) cells, and that a protein known as OX40L was critical to this heightened response. The heightened Th2 response correlated with lower levels of vitamin D as compared with the non-ABPA patients. Adding vitamin D to these cells in the laboratory substantially reduced the expression of OX40L and increased the expression of other proteins critical to the development of allergen tolerance.

"We observed that adding vitamin D substantially reduced the production of the protein driving the allergic response and also increased production of the protein that promotes tolerance," said Dr. Kolls, who also is professor and chair of genetics at LSU Health Sciences Center New Orleans. "Based on our results, we have strong rationale for a clinical trial of vitamin D to determine whether it can prevent or treat ABPA in patients with cystic fibrosis".

Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide), as per the Cystic Fibrosis Foundation. A defective gene and its protein product cause the body to produce uncommonly thick, sticky mucus that clogs the lungs and leads to life-threatening lung infections and obstructs the pancreas and stops natural enzymes from helping the body break down and absorb food.

"These important findings by Dr. Kolls' team add to the growing body of evidence showing that vitamin D may play a critical role on immune responses and allergic diseases," said Juan Celedn, M.D., Dr.P.H., chief of the Division of Pulmonary Medicine, Allergy and Immunology at Children's Hospital.


Posted by: JoAnn    Source




Did you know?
Aug. 25 Vitamin D appears to be an effective treatment to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma, as per scientists from Children's Hospital of Pittsburgh of UPMC, the University of Pittsburgh School of Medicine and Louisiana State University School of Medicine.

Medicineworld.org: Vitamin D to treat allergy in cystic fibrosis patients

Asthma| Hypertension| Medicine| Allergy statistics| How to create a dust free bedroom|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.